Since 2010, Inserm Transfert has been committed to quality management approach which have gradually been extended to all its activities in order to strengthen and adapt our standards continuously throughout the whole value chain.
We have been ISO 9001 v2015 certified since October 2018, for all the processes used to enhance the value of innovations from Inserm laboratories and its partners. Inserm Transfert remains engaged in maintaining and improving the satisfaction of its partners and clients while continuing to adapt to changes in its environment. This approach to quality management, which was initiated as part of a joint effort by all Inserm Transfert departments, is part of the operational management of all activities, implementing :
The quality policy applied by Inserm Transfert aims to ensure that our partners and clients (researchers, institutions and industrial partners) receive high-quality services, the best possible client relationships and the best advice in order to best meet their needs.
Our quality policy is expressed by implementing key operational processes in our mission, having the identification and qualification of the offer and opportunities as a starting point and the monitoring of projects and partnerships as an end point.
Inserm Transfert attaches the utmost importance to customer satisfaction, at both management and staff levels.
In order to continue to improve, Inserm Transfert launched several campaigns in 2024 to measure customer and partner satisfaction with our Intellectual Property and R&D Partnership activities.
In order to meet our partners' expectations in terms of service quality, we considered it essential to gather their opinions on four main areas:
who expressed their opinion recommend Inserm Transfert for the processing of their invention disclosure
who responded recommend Inserm Transfert for setting up partnership contracts
who expressed an opinion recommend Inserm Transfert for setting up partnership contracts
the researchers questioned who had submitted an invention declaration (whether or not a patent application had been filed) were satisfied overall :
for the clarity of the information provided by the patent engineer
of the communication concerning the decision taken on their invention
of the appropriation of the results by the patent engineer for the drafting of the patent application
of exchanges with the patent engineer in the follow-up to the application
In addition, 98% of the researchers questioned felt that the patent application met their expectations.
The researchers questioned were generally satisfied with :
of the quality of discussions with the BD during negotiations
of the time taken to process and implement operating contracts
The industrial partners surveyed were generally satisfied with :
of the quality of discussions with the BD during negotiations
of the time taken to process and implement operating contracts
In addition, 83% of the researchers and industrialists who expressed an opinion were satisfied with Inserm Transfert's overall service in setting up R&D partnership contracts.
Please note: Surveys were sent to 415 researchers (242 for IP activities and 173 for R&D partnership activities)
and 148 industrial partners, with a response rate of 41% (n=139 researcher returns and n=32 industrial returns).
“A lot of intelligence in the management of this file, thank you.”
“I am fully satisfied
”
“I am very satisfied with Inserm Transfert’s services
”
“Clarity and great responsiveness. Thank you very much.”
“Keep up the good work!
”
“Excellent service.”
“
An account manager was appointed and proved to be very competent, very available and her help was decisive with the suggestion of a solution for our contract which was personalised and perfectly appropriate.
”
“Over the last year, Inserm Transfert has improved its exchanges and responsiveness. To be continued. Thank you very much!
”